The MPTP model of Parkinson's disease

The biochemical and cellular changes that occur following administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) are remarkably similar to that seen in idiopathic Parkinson's disease (PD). In this review, we detail the molecular activities of this compound from peripheral into...

Full description

Saved in:
Bibliographic Details
Published inBrain research. Molecular brain research. Vol. 134; no. 1; pp. 57 - 66
Main Authors Smeyne, Richard Jay, Jackson-Lewis, Vernice
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 24.03.2005
Subjects
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Disease Models, Animal
Dopamine - metabolism
Glial cells
Humans
Models, Biological
Neuroglia - physiology
Neurons - physiology
Parkinson Disease - etiology
Parkinson Disease - metabolism
Parkinson Disease - physiopathology
Parkinson Disease, Secondary - chemically induced
Parkinson's disease
Substantia nigra
Substantia nigra
Parkinson's disease
Glial cells
Online AccessGet full text

Cover

More Information
Summary:The biochemical and cellular changes that occur following administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) are remarkably similar to that seen in idiopathic Parkinson's disease (PD). In this review, we detail the molecular activities of this compound from peripheral intoxication through its various biotransformations. In addition, we detail the interplay that occurs between the different cellular compartments (neurons and glia) that eventually consort to kill substantia nigra pars compacta (SNpc) neurons.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0169-328X
1872-6941
DOI:10.1016/j.molbrainres.2004.09.017